FDA Adverse Event Malfunction Summary report: N

KYPHON® ACTIVOS¿ BONE CEMENT WITH HYDROXYAPATITE

MDR report key: 20809009 · Received November 29, 2024

Report

Report Number
6000033-2024-00046
Event Type
Malfunction
Date Received
November 29, 2024
Date of Event
November 9, 2024
Report Date
November 29, 2024
Manufacturer
CARDIAC SURGERY MFG KERKRADE
Product Code
NDN
PMA / PMN Number
SEE H11
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

G2: COUNTRY OF ORIGIN IS I(B)(6). G3 PMA/510(K)#: THE REPORTED PRODUCT C05B IS NOT MARKETED IN US BUT A SIMILAR PRODUCT WITH PRODUCT ID: CX01A, UDI: (B)(4) WITH 510(K)# K102397 IS MARKETED IN US. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (MANUFACTURER REPRESENTATIVE, HEALTHCARE PROVIDER) REGARDING A PRODUCT USED FOR SPINAL THERAPY. IT WAS REPORTED THAT THE MONOMER WAS ALREADY CRYSTALIZED WHILE OPENING THE PACK. THERE WAS NO PATIENT INVOLVEMENT REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2439726 KYPHON® ACTIVOS¿ BONE CEMENT WITH HYDROXYAPATITE CEMENT, BONE, VERTEBROPLASTY NDN CARDIAC SURGERY MFG KERKRADE C05B 229096428

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown